Table 1.
Background characteristics and treatment details in patients with or without preoperative invasive diagnostic modalities (IDM).
Table 2.
Proportion of patients in groups of invasive diagnostic modalities (IDM) based on tumour location.
Fig 1.
Kaplan-Meier graphs of survival for patients +/- preoperative invasive diagnostic modalities (IDM).
a, intravesical recurrence-free survival; b, intravesical recurrence-free survival in diagnostic subgroups A) voided urine cytology, B) retrograde/antegrade pyelography and/or selective urine cytology, C) ureteropyeloscopy with or without obtaining barbotage cytology, or D) ureteropyeloscopy with tumour biopsy; c, overall survival; d, cancer-specific survival.
Table 3.
Multivariable Cox regression analysis of intravesical recurrence (IVR), cancer-specific death and all-cause death in groups of patients with or without invasive diagnostic modalities (IDM).
Hazard ratios (HR) displayed for each outcome are adjusted for tumour location, sex, age, tumour stage, bladder cuff excision, previous bladder cancer, comorbidity (Charlson Comorbidity Index), and education level.